Pfizer, Teva Reach Licensing Deal For Generic Zyvox

Law360, New York (May 31, 2012, 4:15 PM EDT) -- Pfizer Inc. and Teva Pharmaceutical Industries Ltd. have reached an agreement on a licensing deal for a generic version of Pfizer's antibiotic Zyvox, according to a settlement affirmed by a Delaware federal judge on Tuesday.

Pfizer first sued Teva in January 2010 for patent infringement after Teva informed Pfizer that it had filed an abbreviated new drug application with the U.S. Food and Drug Administration.

Teva sought approval to begin making and selling a linezolid injection product in doses of 200 milligrams per 100 milliliters, which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.